As filed with the Securities and Exchange Commission on June 30, 2005
Registration No. 33-85908
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
SYNBIOTICS CORPORATION
(Exact name of registrant as specified in its charter)
| California | 95-3737816 | |
| (State or other jurisdiction incorporation or organization) |
(IRS Employer of Identification No.) | |
| 11011 Via Frontera San Diego, California |
92127 | |
| (Address of principal executive offices) | (Zip Code) | |
1994 STOCK OPTION PLAN
(Full title of the plan)
PAUL R. HAYS
CHIEF EXECUTIVE OFFICER
SYNBIOTICS CORPORATION
11011 VIA FRONTERA, SAN DIEGO, CALIFORNIA 92127
(Name and address of agent for service)
(858) 451-3771
(Telephone number, including area code, of agent for service)
With a Copy To:
Hayden J. Trubitt, Esq.
Heller Ehrman LLP
4350 La Jolla Village Drive
7th Floor
San Diego, CA 92122
This Registration Statement shall become effective immediately upon filing with the Securities and Exchange Commission, and sales of the registered securities will thereafter be effected upon option exercises effected and/or stock issuances made under the 1994 Stock Option/Stock Issuance Plan.
SYNBIOTICS CORPORATION
Deregistration
This registration statement registered 250,000 shares of the Common Stock of Synbiotics Corporation (the “Company”). These shares were offered pursuant to the Company’s 1994 Stock Option Plan (the “Option Plan”). The Option Plan has expired and 2,500 shares have been issued under the Option Plan. Accordingly, the Company hereby deregisters 247,500 shares of the Common Stock originally covered by the registration statement.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on June 30, 2005.
| SYNBIOTICS CORPORATION | ||
| By: | /s/ Paul R. Hays | |
| Paul R. Hays | ||
| President and Chief Executive Officer | ||
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
| SIGNATURE |
TITLE |
DATE | ||
| /s/ Paul R. Hays |
Chief Executive Officer, President and Director (Principal Executive Officer) | June 30, 2005 | ||
| Paul R. Hays | ||||
| /s/ Keith A. Butler Keith A. Butler |
Chief Financial Officer and Vice President – Finance (Principal Financial and Accounting Officer) | June 30, 2005 | ||
| /s/ Thomas A. Donelan |
Director | June 30, 2005 | ||
| Thomas A. Donelan | ||||
| /s/ Christopher P. Hendy |
Director | June 30, 2005 | ||
| Christopher P. Hendy | ||||